A main theory behind the cause of Alzheimer’s disease is the build-up of the protein amyloid-beta in the brain. Researchers from the University of Cincinnati provide evidence suggesting it’s the ...
The research team of Prof.Sung Hoon Kang and Chi Kyung Kim of the Department of Neurology and Prof.Jae Seon Eo of the Department of Nuclear Medicine, Korea University’s Guro Hospital, confirmed that ...
The small molecule spermine has the potential to stop the toxic build-up of proteins in the brain that characterizes diseases ...
On July 2, the U.S. Food and Drug Administration (FDA) approved a new drug for treating Alzheimer’s disease. Donanemab, or Kisunla, is the third drug approved to target one of the causes of ...
The outlook for dementia care is changing fast. UC experts explain what that means for patients and families, and what it ...
Voyager Therapeutics is tripling down on its Alzheimer’s disease franchise, this time with a gene therapy aimed at amyloid-beta plaques. The company broke the news on its second-quarter earnings call ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback